Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
African Ginger (Phyto Nova) is a traditional herbal supplement derived from the rhizomes of the indigenous South African plant *Siphonochilus aethiopicus*. Formulated as a 100mg oral tablet, it was developed and marketed by Phyto Nova Pty Ltd, a South African company focused on traditional African plant medicines. The supplement was traditionally used for its purported anti-inflammatory and bronchodilatory properties to manage respiratory conditions such as asthma, sinusitis, and the common cold, as well as digestive issues. The primary bioactive markers in the extract are sesquiterpenoids, specifically siphonochilone. Phyto Nova Pty Ltd has since been dissolved, and the product is no longer actively marketed by the original developer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on African Ginger.